Arakena Pharmaceuticals was founded in 2024 by two drug hunters and one business-development expert, who decided it was time to build something of their own. With over 60 years of combined pharma and biotech experience, we have contributed to five approved drugs and two more charging ahead in late-stage clinical trials. We have co-authored 100+ publications, filed over 60 patents families, and turned bold science into real medicine.
Our advisor and collaborator team brings deep expertise from bench to bedside. With seasoned professionals in clinical development, cardiology, DMPK, and CMC, we’ve got every angle of drug development covered. Their insights help us stay sharp, move fast, and build smarter — because great science needs great guidance.